OA
GILD icon

Omega Advisors’s Gilead Sciences GILD Stock Holding History

Omega Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-516,989
Closed -$47.5M – 82
2016
Q1 		$47.5M Buy
+516,989
New +$46.6M 1.26% 32
2015
Q1 		– Sell
-612,500
Closed -$57.7M – 105
2014
Q4 		$57.7M Buy
+612,500
New +$63.3M 0.96% 45

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Omega Advisors's GILD Position: Q2 2016 in Review

Omega Advisors sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 516,989 shares — an estimated $47.5M sold.

Omega Advisors first reported a position in GILD in Q4 2014 and held it in 2 quarters. The position peaked at $57.7M in Q4 2014. 1,599 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • Omega Advisors reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
  • Omega Advisors sold 516,989 Gilead Sciences shares in Q2 2016, an estimated $47.5M.
  • Omega Advisors first reported a position in Gilead Sciences in Q4 2014 and held it in 2 quarters.
  • Omega Advisors's Gilead Sciences position peaked at $57.7M in Q4 2014.
  • 1,599 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Omega Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.